Sustained remission with PD-1 and BTK inhibitors maintenance after chimeric antigen receptor T-cell therapy in CNS lymphoma
中枢神经系统淋巴瘤患者在接受嵌合抗原受体T细胞疗法后,使用PD-1和BTK抑制剂维持治疗可获得持续缓解
期刊:Cancer Immunology Immunotherapy
影响因子:5.1
doi:10.1007/s00262-025-04236-4
Yu, Lingzi; Ping, Nana; Zou, Rui; Zhu, Qian; Li, Junhong; Zhang, Xiao; Xia, Fan; He, Jiajie; Tu, Jiajie; Kong, Danqing; Wu, Depei; Jin, Zhengming; Qu, Changju
T细胞
信号转导
淋巴瘤
神经科学
T细胞
BTK
细胞生物学
PD-1
免疫/内分泌